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Preliminary normative data for a new device to measure dynamic visual acuity 
Abstract 
PURPOSE: Historically, dynamic visual acuity (OVA) measurement relied on instruments that presented a 
moving target at a high velocity that was gradually slowed until the subject could correctly identify it 
(head stable, target moving). This type of testing, however, bears little resemblance to typical OVA stimuli 
encountered in daily life. The purpose of this project is to introduce preliminary normative data for a new 
device using a stationary stimulus viewed during calibrated head movements to measure OVA. This 
condition is much more representative of the OVA tasks encountered in everyday life. 
METHODS: Fifty-four subjects aged 23-57 years were evaluated using the inVision™ system (NeuroCom® 
International, Inc.). The PC-based instrument presents a tumbling E stimulus when the subject achieves a 
given head movement velocity as monitored by a head-borne accelerometer. Subjects are instructed to 
move the head to and fro (as if to say "no") at differing velocities. When the target head velocity is 
reached, a tumbling E is presented on the computer monitor and the subject must make a forced choice 
regarding the orientation of the stimulus. Data were obtained for two protocols: OVA (head velocity is held 
constant and the stimulus size is gradually reduced) and gaze stabilization (stimulus size is held constant 
and head velocity is increased). 
RESULTS: The inVision™ system demonstrated excellent testability, all fifty-four subjects were able to 
complete both test protocols. With increasing age, there appears to be a trend toward decreasing 
performance, but no statistical significant differences were found. Further testing involving older subjects 
is needed to uncover more definite trends with age. When the data were analyzed by refractive category, 
high myopes (>4.000) performed significantly poorer on the OVA test. There were no differences in this 
group based on static visual acuity, age, or type of correction. 
CONCLUSION: While the inVision™ system is currently being used mostly in vestibular/ENT cl inical 
settings, it offers intriguing potential for utilization in optometric science. Previous studies have shown 
that OVA performance cannot be predicted by other tests commonly used in optometric patient 
evaluations, and our results suggest the same. Hence, this instrument may provide a unique new 
assessment tool to aid the clinician in the diagnosis and management of visual conditions that cannot be 
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PRELIMINARY NORMATIVE DATA FOR A NEW DEVICE TO MEASURE 
DYNAMiC VISUAL ACUITY 
Abstract 
PURPOSE: Historically, dynamic visual acuity (OVA) measurement relied on 
instruments that presented a moving target at a high velocity that was gradually 
slowed until the subject could correctly identify it (head stable, target moving). 
This type of testing, however, bears little resemblance to typical OVA stimuli 
encountered in daily life. The purpose of this project is to introduce preliminary 
normative data for a new device using a stationary stimulus viewed during 
calibrated head movements to measure OVA. This condition is much more 
representative of the OVA tasks encountered in everyday life. 
METHODS: Fifty-four subjects aged 23-57 years were evaluated using the 
inVision™ system (NeuroCom® International, Inc.). The PC-based instrument 
presents a tumbling E stimulus when the subject achieves a given head 
movement velocity as monitored by a head-borne accelerometer. Subjects are 
instructed to move the head to and fro (as if to say "no") at differing velocities. 
When the target head velocity is reached, a tumbling E is presented on the 
computer monitor and the subject must make a forced choice regarding the 
orientation of the stimulus. Data were obtained for two protocols: OVA (head 
velocity is held constant and the stimulus size is gradually reduced) and gaze 
stabilization (stimulus size is held constant and head velocity is increased). 
RESULTS: The inVision™ system demonstrated excellent testability, all fifty-four 
subjects were able to complete both test protocols. With increasing age, there 
appears to be a trend toward decreasing performance, but no statistical 
significant differences were found. Further testing involving older subjects is 
needed to uncover more definite trends with age. When the data were analyzed 
by refractive category, high myopes (>4.000) performed significantly poorer on 
the OVA test. There were no differences in this group based on static visual 
acuity, age, or type of correction. 
CONCLUSION: While the inVision™ system is currently being used mostly in 
vestibular/ENT cl inical settings, it offers intriguing potential for utilization in 
optometric science. Previous studies have shown that OVA performance cannot 
be predicted by other tests commonly used in optometric patient evaluations, and 
our results suggest the same. Hence, this instrument may provide a unique new 
assessment tool to aid the clinician in the diagnosis and management of visual 
conditions that cannot be quantified using static methods of visual assessment. 
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Dynamic visual acuity (OVA) is typically defined as the visual resolution 
during relative motion of either target or observer. 1 The history of OVA research 
can be traced back to the 1940s, and many established facts are still accepted 
today. These include: as target velocity increases, an observer's acuity 
decreases markedly; observers with identical static acuity can differ greatly in 
their OVA; OVA is sensitive to changes in target energy, even at levels for which 
static acuity has plateaued; OVA appears to be more closely related to real-world 
tasks (i.e. driving or flying) than are traditional visual acuity (VA) measures.2 
Burg, in 1966, established that OVA shows a striking age-related decline in 
performance, with those over forty showing a marked decline for the high target 
velocities. 3 A significant illuminance effect was established by Long in 1990, 
demonstrating vastly improved performance with high illumination levels.2 
Considering these illuminance data, Long suggested the cause of age-related 
OVA loss to be optical in nature (thickening of the lens and pupillary miosis), 
rather than attributing the loss to neuromuscular or post-retinal changes with age. 
Gender seems to play no role in OVA performance.2 
OVA is not currently evaluated as standard protocol in examinations of the 
eyes and visual system. It has been proposed that OVA should be evaluated for 
a variety of reasons. One area where information regarding functional OVA 
would be ex .aly useful is in the evaluation of elderly drivers. Elderly drivers 
have higher accident rates than all other drivers in the US (besides those 25 
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years of age and younger).4 Also, vestibule-ocular reflex (VOR) 
performance.5•6•7•8•9•10 and indications of vestibular pathology11 •12•13•14 can be 
inferred by measuring OVA. The VOR causes fast eye movement in the opposite 
direction of head movement for the purpose of maintaining fixation on a target of 
interest. In normals, the VOR helps to maintain visual acuity while fixating a 
stationary target during head movement. In certain disorders, however, the VOR 
may be compromised, leading to a dramatic decrease in visual acuity as the 
velocity of head movement increases. Studies have shown that in subjects with 
unilateral vestibular dysfunction, the decrease in OVA is much worse with 
ipsilesional head rotation than with contralesional rotation. 15 This finding was 
associated with significantly decreased VOR gain with ipsilesional head rotation 
but normal VOR gain with contralesional rotation. The decreased VOR gain 
could be the primary explanation for the greater OVA loss in only one direction. 
This and similar studies suggest another possible application for the 
measurement of OVA: diagnosing and monitoring patients with unilateral 
vestibular dysfunction. 
Pursuit tracking ability can be indirectly assessed via OVA performance. 16 
OVA has been found to be significantly better among athletes than their non-
athletic peers. 17 Better OVA can also be indicative of better rehabilitative 
success in patients utilizing telescopic spectacles as low-vision devices. 18 For 
these and numerous additional purposes, the importance of OVA testing is 
apparent. 
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Some previous inadequacies in theory and protocol have prompted a new 
approach to DVA testing. Historical measurement methods usually used 
instrumentation that involved a moving target (often circular movement) with a 
stationary observer. 19 Not only is this instrumentation no longer available, but it 
provided an incomplete assessment of DVA since there was no movement of the 
subject. For previous methods that involved movement of the subject, a 
disadvantage to head-on-torso rotation was the inability to maintain control and 
isolate head rotation (versus whole body rotation). 15 Also, previous testing 
involved extrapolating from eye movement records to the subject's performance 
regarding resolution of moving targets.2 Very limited testing has been done 
requiring subjects to move their heads, as opposed to pursuing a moving target. 
Other design deficiencies, cited by Derner, include: velocity and frequency 
characteristics of imposed head motion have been poorly controlled and often 
have been unmonitored; optotypes have been presented continuously, even 
during low or even zero head velocity periods; the variation in letter size from line 
to line in the optotype charts has been non-uniform, making reliability poor and 
acuity resolution uncertain; and measures have not been taken to prevent 
memorization of the contents of the charts. 12 Herdman also noted some 
experimental design problems, including: uncontrolled periods in which head 
movement slowed so that pursuits or fixations could be utilized instead of the true 
VOR; no computerized system has examined test reliability; no computerized 
system has examined the effect of age on visual acuity during head movement; 
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and no study has determined the sensitivity and specificity of computerized DVA 
in identifying subjects with vestibular deficits.13 
With the aforementioned problems in mind, NeuroCom® International, Inc. 
developed a computer-based protocol for measuring DVA. The company was 
founded in 1984, and is headquartered in Clackamas, OR. Their inVision™ 
instrument was developed as a complement to their full line of clinical vestibular 
diagnostic and treatment instrumentation. The inVision™ device was developed 
in 2003 and approximately 50 units are in use around the world. NeuroCom 
pioneered the development of Computerized Dynamic Posturography (CDP), a 
testing protocol that has become a worldwide diagnostic standard for 
assessment of balance and postural control. Initially, CDP was developed for the 
purpose of evaluating the effects of space flight on vestibular function and 
balance control and was funded by grants from NASA. The National Institutes of 
Health have sponsored research using COP to study the effects of disease on 
balance and mobility functions. Since COP provides a measure of visual-
vestibular interaction related to otolith function, the inVision™ instrument is a 
useful companion device since it provides information about visual-vestibular 
interaction related to semicircular canal function and the VOR. These 
instruments are used in both clinical and academic settings to study a great 
diversity of acute and chronic disorders. The technology developed by 
NeuroCom® has been used in a variety of medical disciplines including 
otolaryngology, neurology, geriatrics, sports medicine, and physiatry.20 
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Measuring OVA with inVision™ involves rotation of the head on the 
stationary torso, while fixating a stationary target. This variation of movement 
mimics a more natural mode of head motion commonly encountered in everyday 
life. With this mode of testing, other motor mechanisms in addition to the VOR 
can be evaluated. Using a similar computerized method to assess OVA, a 
significant relationship was reported between age and OVA scores with older 




Fifty-four adult volunteers participated in this study, ranging in age from 
23-57 years. There were 23 men and 31 women. Each volunteer gave written 
informed consent (See Appendix 1) to participate in the protocol as approved by 
the Institutional Review Board at Pacific University. All subjects filled out a 
personal and family health history form used for routine patient care at the Pacific 
University Family Vision Center in Forest Grove, OR (See Appendix 2). 
Questions pertained to personal and family history of diabetes, high blood 
pressure, heart problems, thyroid problems, cancer, glaucoma, cataracts, 
macular degeneration, crossed eyes, amblyopia, reading problems, or high 
cholesterol. The subjects also answered personal questions regarding problems 
with breathing, liver, stomach, kidney, sinuses, nerves, and HIV/AIDS. In 
addition, subjects responded negatively to a set of questions orally administered 
that ruled out any vestibular dysfunction, ear problems, or head injuries. Subjects 
were also questioned about their highest education level, current medications, 
any current optical prescription (type and power), preferred hand, and preferred 
foot. 
Subjects then underwent pre-testing which included 6 meter monocular 
visual acuity using a log MAR chart, cover test at distance and near, ocular 
sighting preference, and 40 em stereoacuity. Ocular sighting preference was 
determined using the following protocol: one hand was placed on top of the 
other, forming a small triangular window. Keeping both eyes open, the subject 
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was asked to fixate the examiner's right eye then raise the hands until they could 
view the examiner's eye through the "window". Then the subject was asked to 
lower the hands, fixate the examiner's left eye, and repeat the procedure. The 
subject was instructed to switch the orientation of the hands so that the opposite 
hand was on top and repeat the procedure for each of the examiner's eyes, as 
before. In this way, four trials for sighting preference were performed and it was 
noted which eye was preferred and how strongly it was preferred (50%, 75%, or 
1 00%). Stereoacuity was determined using the Randot nearpoint stereo test 
(available from Bernell Corp. at www.bemell.com) with stimuli as fine as 20 sec 
arc. All tests were performed in the same room with ambient lighting of 
approximately 110 lux measured at the subject's forehead. 
The inVision ™ instrumentation developed by NeuroCom® and used in this 
experiment is composed of a standard desktop PC with flat LCD screen, the 
appropriate software to run the experiments, a posturography platform, and an 
inertia cube (a headborne accelerometer). The instrument was specifically 
designed for the measurement of OVA using a stationary target with head-on-
torso rotation. OVA can be measured for yaw, pitch, and roll rotation axes; only 
yaw rotation was investigated in this study. 
Each subject first performed a modified Clinical Test of Sensory 
Interaction and Balance (CTSIB)21 '22'23 to ensure adequate baseline vestibular 
function and balance (see Figure 1 ). During this test, the subject removed the 
shoes and attempted to stand straight and still, with arms at the sides, on a hard 
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surface, first with eyes open for three trials (10 seconds each) then with eyes 
closed for three trials (1 0 seconds each). This was immediately followed by the 
subject standing on a soft foam surface, with eyes open and then eyes closed, in 
the same manner as the hard surface. The purpose of administering this 
Figure 1 . Subject standing 
on the posturography 
platform used for CTSIB 
(foam pad in place). 
screening test was to insure that each subject's postural sway in each of the four 
conditions was within normal limits. After performing this test successfully, the 
subject was permitted to move on to the next section. 
The subject was seated on a padded non-rolling, back-supported chair at 
a distance of 10 feet from the computer screen. The inertia cube was placed on 
the subject's head and properly adjusted so that it would not slide with head 
movement. The subject's static visual acuity was then re-measured using the 
inVision™ protocol involving a black tumbling E stimulus in one of four 
orientations: left, right, up, or down in the center of a white LCD screen. The 
subject made a four-alternative forced choice to identify the orientation of the 
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tumbling E. The program continued presenting smaller stimuli in staircase 
fashion until threshold was reached (3/5 incorrect). 
One of two tests was performed next. The order of the two tests was 
assigned to each subject in an alternating fashion. One test was Dynamic Visual 
Acuity (OVA) and the other was the Gaze Stabilization Test (GST). For the OVA 
test, the subject was instructed to move the head back and forth about the yaw 
axis (as if saying "no") while keeping their eyes on the screen. During the 
practice period, a practice screen appeared that provided feedback about how 
fast the head was moving. The subject was encouraged to move the head in a 
large, sweeping motion rather than rapidly jiggling the head back and forth with a 
small angle of motion. The first 14 subjects tested were asked to reach a 
minimum head velocity of 120 deg/sec in order to elicit stimulus presentation. 
However, this velocity was difficult for some subjects to achieve, so the protocol 
was changed to require a minimum head velocity of 85 deg/sec, for the 
remaining 40 subjects. The actual head velocity during stimulus presentation was 
recorded. When the subject felt comfortable moving the head at the appropriate 
speed, the test began. During the test, the screen was white except for a large 
thin black circle in the center of the screen. 
When the subject's head reached a velocity of at least 85 deg/sec, a 
tumbling E stimulus was presented for 75 msec in the center of the circle on the 
screen (see Figure 2). Immediately following the stimulus, subjects made a four-
alternative forced-choice decision about the orientation of the E. The test 
continued with stimuli presented in a descending staircase until the subject 
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reached a threshold for dynamic visual acuity (3 of 5 trials incorrect). If during 
any trial the subject failed to reach the desired head velocity within a few 
Figure 2. Cartoon 
portrayal of stimulus 
screen viewed by 
subjects. Diameter of 
circle: 9 em for viewing 
distance of 1 0 ft. 
seconds, the practice screen reappeared and the subject was instructed to again 
practice the appropriate head movement. The threshold acuity was recorded for 
rightward and leftward head movement separately in order to note any 
discrepancies between the two directions. The protocol yielded a OVA measure 
and a terminal head velocity measure for both rightward and leftward movement. 
Subjects' terminal head velocity (the actual head velocity when the OVA 
threshold was measured) was typically slightly faster than the minimum required 
velocity. The program also calculates "OVA Loss," the difference between the 
subject's static visual acuity and the threshold OVA value in each direction. 
The GST was performed in a similar manner, either before or after the 
OVA test as assigned. However, for GST the size of the stimulus was held 
constant at 0.2 logMAR larger than the subject's static threshold (but never 
smaller than 0.0 logMAR) and the subject moved the head progressively faster to 
trigger the stimulus. The test began with a minimum head movement velocity of 
- 15-
80 deg/sec to trigger the stimulus. As the subject responded correctly, the 
minimum velocity was increased in steps of 10 deg/sec until threshold (3/5 
incorrect) was reached. As with OVA, the instrument recorded the threshold 
velocity for rightward and leftward head movement separately. Results of the 
GST testing were presented as the threshold velocity the subject was able to 
reach, in deg/sec, while maintaining a visual acuity of 0.2 logMAR larger than the 
static acuity threshold. 
After performing both the OVA and GST tests, subjects performed the 
modified CTSIB test again to demonstrate whether or not performing the tests 
had an effect, either positive or negative, on their balance or vestibular 
functioning. The entire testing sequence lasted about 25 minutes. The 




Dynamic measures from inVision® were analyzed using one-way ANOVA 
for independent groups based on different categorical grouping variables. 
Acceptable probability was set at p < 0.05. The final dataset consisted of 54 
subjects. Grouping categories included type of Ax (specs, CL's, none), refractive 
condition category (low myopia, high myopia, emmetropia), heterophoria 
category, preferred sighting eye, education level, and age by decade. Each 
category was analyzed to detect differences in left OVA, right OVA, left OVA loss, 
right OVA loss, left terminal head velocity during OVA, right terminal head 
velocity during OVA, left GST, and right GST. 
Several of our tested categories showed no difference in performance in 
any of the above variables. Regarding gender, no differences were found between 
the performance of males and females. Education level also showed no 
differences whether the subject completed high school, bachelor's degree, or 
graduate level. There were no differences whether the subject completed the OVA 
or GST test first. Phoria at distance also showed no difference, in any degree of 
eso or exo phoria. No differences were found between right and left ocular 
sighting preference, whether the preferencfl was 1 00%, 75%, or 50%. Regarding 
hand preference, valid analyses could not be run, due to the imbalance between 
right- and left-handedness; only three subjects were left-handed. Type of optical 
prescription (spectacles, contact lenses, or none) used was not associated with 
any consistent difference in the dynamic measures. 
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Refractive category was analyzed for three groups: emmetropes, high 
myopes (4 diopters or greater), and low myopes. High myopes performed 
significantly poorer on left OVA, right OVA, left OVA loss, and right OVA loss. 
These refractive categories were also analyzed for differences regarding static 
visual acuity, age, or type of prescription, but no significant differences were 
found. Therefore, the reason for high myopes performing poorer cannot be 
attributed to the aforementioned variables. 
The dependent variables mentioned above were also analyzed for 
differences between the following age groups: 20s, 30s, 40s, and 50s. There 
were 27 subjects in the 20's decade and 9 each in the 30's, 40's, and 50's. With 
increasing age, there appears to be a trend toward decreasing performance, but 
no significant differences were found. An apparent age-related difference in OVA 
terminal velocity was found (see figure 3), although this result is confounded by a 
difference in testing protocol. Most of the older subjects were tested using a 
slower initial OVA velocity than were most of the younger subjects. 
Mean velocity during rNA test (L+RI2) 
20's 30's 40's 
Age by decade 
50's 
Figure 3. Average OVA 
terminal velocity for the 
four age groups, 
demonstrating a decrease 
in OVA velocity for older 
subjects. 
Regarding GST velocity, no age-related decrease in terminal velocity was found 
(see figure 4). 
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Figure 4. Average GST 
terminal velocity for the 
four age groups, 
demonstrating no apparent 
change in GST velocity for 
any age group. 
Average OVA was also compared for each of the four age groups; no differences 
were found. 
OVA loss, the difference between a subject's static and dynamic VA 
thresholds, was also analyzed between age groups and no differences were 
found. Average OVA loss for all groups was approximately 0.2 logMAR units. 
(See figure 5) . 
. .. --- --------- -----------------. 




Age by decade 
Figure 5. OVA loss by 
age group showing no 
differences by decade of 
age. 
Data were tabulated and grouped by age (see Table 1) and refractive 
category (see Table 2). All variables that showed a s!gnificant difference at 95% 
confidence are marked with an asterisk (*). 
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Table 1. Variables grouped by age. 
20's 30's 40's 50's 
std std std std 
Variable value dev n value dev n value dev n value dev n 
Var 1: SVA (log MAR) -0.18 0.03 27 -0.14 0.13 9 -0.15 0.04 9 -0.12 0.11 9 
Var 2: LFGST 104.44 32.85 27 94.44 32.05 9 92.22 22.79 9 103.33 30.41 9 
Var 3: RBGST 98.14 26.89 27 96.66 25.49 9 96.66 32.01 9 87.77 25.87 9 
Var4: LFGST 
(logMAR) 0.01 0.03 27 0.05 0.13 9 0.04 0.04 9 0.07 0.11 9 
Var 5: RBGST 
(logMAR) 0.01 0.03 27 0.05 0.13 9 0.04 0.04 9 0.07 0.11 9 
Var 6: GST vel L+R/2 101.29 27.61 27 95.55 26.74 9 94.44 23.51 9 95.55 27.20 9 
Var7: LDVA 0.011 0.10 27 0.04 0.14 9 0.07 0.09 9 0.07 0.12 9 
Var 8: RDVA 0.05 0.13 27 0.07 0.14 9 0.05 0.10 9 0.08 0.16 9 
*Var 9: L Vel 123.92 23.25 27 120.33 22.58 9 116.66 15.62 9 108 8.10 9 
*Var 10: R Vel 123.11 19.63 27 114 21.58 9 112.11 14.87 9 107.55 9.47 9 
Var 11: Left loss -0.19 0.09 27 -0.18 0.11 9 -0.23 0.06 9 -0.2 0.07 9 
Var 12: Right loss -0.23 0.12 27 -0.21 0.05 9 -0.21 0.07 9 -0.21 0.11 9 
Var 13: L+R/2 loss -0.21 0.09 27 -0.20 0.08 9 -0.22 0.06 9 -0.20 0.08 9 
"Var 14: DVA vel 
L+R/2 123.85 20.80 27 117.55 22.11 9 114.66 12.64 9 108.11 7.20 9 
* significant at 95% 
Table 2. Variables grouped by refractive category. 
Emmet ropes Low myopes High myopes 
Variable value std dev n value std dev n value std dev n 
Var 1: SVA (logMAR) -0.16 0.09 21 -0.17 0.03 20 -0.13 0.10 10 
*Var 7: L DVA 0.02 0.11 21 0.01 0.10 20 0.13 0.09 10 
··var 8: R DVA 0.02 0.13 21 0.03 0.10 20 0.17 0.13 10 
*Var 11: Left loss -0.18 0.08 21 -0.18 0.08 20 -0.26 0.09 10 
*Var 12: Right loss -0.18 0.09 21 -0.21 0.09 20 -0.31 0.10 10 
•var 13: L+R/2 loss -0.18 0.07 21 -0.2 0.07 20 -0.28 0.08 10 
Var15:age 35.23 11.32 21 33.1 10.64 20 34.4 12.58 10 
• Significant at 95% 
*Significant at 95% 
**Significant at 95% but confounded by change in protocol 
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DISCUSSION 
The results presented here represent early findings of an ongoing study to 
generate normative data for the inVision® device. Because we continue to 
acquire data, especially for older subjects, any conclusion based on the current 
data set must be considered preliminary. 
The authors looked for any differences in OVA performance based on age 
by decade, refractive condition, type of optical prescription worn, preferred hand, 
ocular sighting preference, heterophoria, education level, and gender. 
The current study found no significant effect of aging on OVA, OVA 
terminal velocity, or OVA loss. However, previous studies have found a 
significant loss only for subjects over age 65. 13 This study included subjects up 
to age 57. Further studies using this device are planned which will include older 
subjects and larger numbers of middle-aged subjects that may result in a more 
conclusive understanding of the relationship between age and OVA loss using 
the inVision™ device. 
Our results indicate that individuals with myopia of 4.0 D or greater, 
regardless of type of optical prescription, demonstrate poorer OVA than do 
individuals with lesser myopia or emmetropia. These subjects did not differ on 
any other measured variable. This finding is interesting and suggests that 
dynamic visual acuity may be compromised associated with higher amounts of 
myopia. A larger sample size is necessary to establish whether this finding is 
repeatable. 
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Other laboratories using inVision® have reported anecdotal concerns that 
patients wearing progressive addition lenses (PAL's) seem to have greater 
difficulty with OVA and GST assessment than do patients with other types of 
prescription eyewear. It might be expected to find poorer DVA performance in 
subjects wearing PAL's due to the distortion present in the periphery of the 
lenses and the necessity to view the stimulus through this portion of the lens at 
times during head rotation. We found no difference in performance that could be 
attributed to PAL's, however our sample (n=7) of PAL wearers was very small. 
A larger sample of these subjects is needed for clarification of whether an effect 
of PAL's on OVA exists. 
Regarding preferred hand, ocular sighting preference, heterophoria, 
education level, and gender, we found no differences in DVA or GST associated 
with these variables. Additionally, correlations between the static vision 
measurements (VA, refraction, phoria, stereo acuity) and the inVision® dynamic 
measures were uniformly low, suggesting that inVision® may be measuring 
aspects of visual function that have heretofore been ignored in routine visual 
function testing. 
When comparing OVA loss for rightward versus leftward head movement, 
there was no significant difference between the two directions. This is an 
important finding to note in the current study of normal subjects because 
previous studies have shown a significant difference between leftward and 
rightward motion in DVA loss for patients with unilateral vestibular loss.13•15 
These researchers have proposed computerized DVA assessment protocols, 
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similar to that used in the current study, as a possible mode of diagnosing 
vestibular disorders and monitoring patient progress in rehabilitation. 
In addition to the potential this device holds for vestibular dysfunction 
patients, we believe the inVision® device has numerous applications in 
optometry as well. It has been shown that OVA cannot be predicted by other 
measures commonly used in the optometric test battery, such as static visual 
acuity,2 and our results suggest that the device measures aspects of visual 
performance that are distinct from the static measures that are part of routine 
vision assessment. As such, it is possible that clinical measurement of OVA and 
or GST may yield insights for patients who express concern about motion-related 
visual function. We are also interested in the potential application of the device 
in high-demand visual tasks such as sport activities. We are currently testing 
college athletes and hope to present those data soon. It has been suggested 
that OVA can be trained,24 hence the inVision® device could be used either to 
assist in training or to monitor improvement with training. 
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Informed Consent to Act as a Research Participant 
Dynamic Visual Acuity Normative Data 
Investigator(s) Contact Information 
Dr. Bradley Coffey 




1. Introduction & Background Information 
coffeyb@pacificu.edu 
o lmschenk@pacificu. edu 
leahr@pacificu. edu 
You are invited to be in a research study of normative data for a new method of measuring dynamic visual 
acuity. You were selected as a possible participant because you signed up on the interest sheet. Please read 
this form carefully and ask any questions you may have before agreeing to be in this study. This study is being 
conducted by Dr. Bradley Coffey. The purpose of this study is to obtain normative data for various age groups 
n:>r a new method of measuring dynamic visual acuity. 
:2:. Procedures 
If you agree to be in this study, we will ask you to do the following things: You will wear a measurement 
device on your head and complete three tasks: computerized posturography, gaze stabilization, and dynamic 
visual acuity. The first task involves attempting to stand still on both a firm surface and a foam pad, both with 
eyes open and with eyes closed. For the gaze stabilization test, you will sit in a chair ten feet from a computer 
~:creen wearing lightweight headgear while swinging your head back and forth horizontally. When your head 
is moving fast enough, a Snellen tumbling "E" will appear on the screen and you will be asked to identify the 
::orrect orientation verbally. If you identify the orientation correctly, the rate ofhead movement is 
incrementally increased until you are unable to correctly identify the stimulus of constant size. The dynamic 
·;isual acuity test consists of the same setup as the gaze stabilization test. For this test, the rate of head 
rnovement remains constant while the size of the stimulus letter is incrementally decreased until you can no 
l::mger correctly identify it. You will spend about 30-40 minutes for the testing and will not need to return. 
3. Risks & Benefits 
None of the procedures conducted during the dynamic visual acuity study should pose any significant risks. 
During head rotation, there is a small risk that you may experience symptoms of dizziness, nausea, and/or 
motion sickness. There is also a small risk of neck injury due to head rotation. You will be in full control of 
vour head movement during the entire testing procedure and may report these symptoms at any time to the 
'~xperimenters and/or request to discontinue the testing. If you are experiencing these symptoms, you should 
not drive a motor vehicle until the symptoms subside. Possible benefits include further knowledge gained 
about dynamic visual acuity and particularly this method of measuring it. The data from this study will be 
used as comparative data for NASA astronauts who have completed the same testing protocol. 
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4l. Alternatives Advantageous to Participants 
Not applicable 
5. Participant Payment 
You will not receive payment or compensation for your participation 
~. Promise of Privacy 
The records of this study will be kept private. The individual data will be kept on the computer in the 
research lab which remains locked at all times. Ifthe results of this study are to be presented or published, we 
will not include any information that will make it possible to identify a participant. Research records will be 
~tored securely and only researchers will have access to the records. 
~!.Voluntary Nature ofthe Study 
Your decision whether or not to participate will not affect your current or future relations with Pacific 
University. If you decide to participate, you are free to not answer any question or withdraw at any time 
1.vithout prejudice or negative consequences. 
'1. Compensation and Medical Care 
During your participation in this project you are not a Pacific University clinic patient or client, nor will you 
) e receiving complete care as a result of your participation in this study. If you are injured during your 
participation in this study and it is not the fault of Pacific University, the experimenters, or any organization 
associated with the experiment, you should not expect to receive compensation or medical care from Pacific 
~ Jniversity, the experimenters, or any organization associated with the study. 
;;.'l . Contacts and Questions 
The experimenters will be happy to answer any questions you may have at any time during the course of the 
study. The experimenter can be reached at 503.352.2880 or by email at coffeyb@pacificu.edu. If you are not 
.;atisfied with the answers you receive, please call the Institutional Review Board Chair, Dr. Karl Citek, at 
503) 352-2126 to discuss your questions or concerns further. Although Dr. Citek will ask your name, all 
;omplaints will be kept in confidence. 
f; 0. Statement of Consent 
I have read and understand the above. All my questions have been answered. I am 18 years of age or older. I 
~c.ave been given a copy of this form to keep for my records. 
Participant's Signature ----------------- Date --------
,:' articipant's printed name ------------------
;~nvestigator's Signature ------------------- Date --------
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VISION AND GENERAL HEALTH PRELIMINARY HISTORY FORl\1 
)f. Patient Name. ________________ _ 
.:f- Date ________ Date of Birth 
--------
Thank you for taking the time to carefully complete this fonn. Your answers to these questions help us to 
develop a clear picture of your visual an~_general health conditions. All of your responses are kept confidentiaL 
REASON FOR VISIT 
What is the primary reason for your visit to our clinic today? ________________ _ 
I may be interested in (circle a1llhat.apply): 




Colored Contact Lenses 
Contacts for Astigmatism 
Bifocal Contacts 
Vision Therapy 
Rehabilitative Vision Care 
Crossed Eye Treatment 
Nearsightedness Control 
Refractive Surgery 
Low Vision Services 
Lazy Eye Treatment 
Sports Vision Care 
Polaroid Lenses 
Sports-Related Eyewear 
UV Protection Thiimer-Lighter Lenses Anti-glare Coatings 
Lenses that Chan,ge Color Occ~~tional Safety Eyewear · 
EYE HEALTH AND VISION INFORMATION 
Do you currently wear glasses? ................. ....... 0 Yes 0 No 0 Yes, but not all the time 
Do you currently wear contact lenses?................ 0 Yes 0 No 0 Yes, but not all the time 
Do you have vision problems using a computer?.... 0 Yes . 0 No 0 Y es,.but not all the time 
When was your last vision examination? Cliillc or Doctor's name? _______ ~--
Do you have (or have you ever had) any of the folJowir.g eye or vision problems? (circle any or all that apply) 
Blurred vision Dizziness . Eye injuries Poor night vision Crossed or ''lazy" eye 
Double vision ·Red eyes Eye infections Poor depth perception, Tired or irritated eyes 
Headaches Dry eyes Eye surgeries Hashes of light Low reading comprehension 
~1oticn sickness floaters in vis~on 
Other eye o:- vision Jlroblems: _________ , ____ _ 
HOW DO YOU USE YOUR EYES? 
What is your occupation (or grade level if you· are a stui:lent)? ____________ _ _ 
Please circle any of the fol1owing tasks and activities. in which you participate. 
Reading Gardening Carpentry Tennis Swimming Computer use 
Music Driving Logging Ski inn ~ Homemaking Public sp~aking 
Sewing Office work Golf Fishing Football Hunting/Shooting 
Television Teaching Welding Bowling Baseball Arts and crafrs 
Sales Mechanic Boating Racquetball Basketball Activities in the sunshine 
Other occu ations. hobbies, etc .... 
Please ~turn this page over and complete the other side ] · 
10!9!\ 
MEDICAL INFORMATION 
D3 you currenLJy take illY medications (prescription or .. Over the Counter")? .................. . DYes ONo 
Please Jisl:. ________________________ _ 
Do you have allergies to any medications? ... ...... ,. ......... .. ............... .:-··-········ ·-·-··· ··· OYesONo 
Please list: 
·-------------------------------------
Do you have any other aJJer~ies? ..................................................... ................ . 0 Yes ONo 
Please list:. _______________________________ _ 
A 1 . ., re you current y pregnant or ilursmg .................. ............................................ . DYes ONo 
·\Vben was your last medical examination?. _______ Clinic or Doctor's name? ______ _ 
-
-
PERSvNAL and ~AMILY HISTORY 
Many vision and general health problems tend to run in fam.uies. Pje;.:se indicate below if you or your family 
members have any of the following problems. 
Do vou . ha1·e? family member has? RelatiQnshin tQ xou? 
Diabetes DYes QNo QUIL'rnown aYes ONo OUnknown 
High blood pressure DYes ONo QUnlcnown DYes QNo 0 Unknown 
Heart proble.m.~ DYes ONo QUnknown DYes DNo 0 Unknown 
Thyroid problems DYes ONo QUnknown OYes DNo OUnknown 
Cancer DYes ONo QUnknown DYes DNo OUnknown 
Glaucurna DYes ONo D Unknown DYes "' DNo OUnknown 
Cataracts DYes ONo QUnknown DYes DNo OUnknown 
-
Macul~ degeneration DYes ONo OUnknown_ DYes ONo QUnknown 
1 Crossed eyes (strabismus) DYes ONo QUnknown DYes o"No QUnknown 
PJDblyopia Oazy eye) DYes ONo OUnkilown DYes D~o OUnknown 
Readingprob.(dyslexia) 0 Yes ONo QUnknown DYes QNo QUnknown 
High cholestero! DYes ONo QUnknown DYes QN0 QUnknow.:~ 
Breathing problems DYes ONo QUnknown 
Liver problems DYes ONo DUnknown Other Conditions DYes DNo 
Stomach problems DYes ONo QUnknown (Please Describe) 
Kidney problems DYes QNo QUnknown 
Nerve problems QYes DNo 0 Unkuown 
I Sinus proble~s DYes DNo QUnknown 
illV~AIDS OYes ONo OUnknown 
-
( Patient Signature. ________________________ Date. ____ _ 
Attending Doctor Signature. _____________________ Date. ____ _ 
Please turn this -age over and com Jete the other side 
